These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 25533886

  • 1. Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: a multicenter, open-label, uncontrolled study.
    Kohno S, Tateda K, Mikamo H, Kadota J, Niki Y, Itamura R.
    J Infect Chemother; 2015 Mar; 21(3):182-8. PubMed ID: 25533886
    [Abstract] [Full Text] [Related]

  • 2. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
    Kohno S, Yanagihara K, Yamamoto Y, Tokimatsu I, Hiramatsu K, Higa F, Tateyama M, Fujita J, Kadota J.
    J Infect Chemother; 2013 Dec; 19(6):1035-41. PubMed ID: 23695232
    [Abstract] [Full Text] [Related]

  • 3. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
    Okimoto N, Kurihara T, Honda N, Asaoka N, Fujita K, Ohba H, Nakamura J.
    J Infect Chemother; 2003 Jun; 9(2):183-6. PubMed ID: 12825120
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia.
    Yanagihara K, Fukuda Y, Seki M, Izumikawa K, Higashiyama Y, Miyazaki Y, Hirakata Y, Tomono K, Mizuta Y, Tsukamoto K, Kohno S.
    Intern Med; 2006 Jun; 45(17):995-9. PubMed ID: 17015999
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.
    Williams D, Perri M, Zervos MJ.
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):293-8. PubMed ID: 8070432
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y, Watanabe A, Goto H, Matsushima T, Abe S, Aoki N, Shimokata K, Mikasa K, Niki Y, Kohno S.
    J Infect Chemother; 2012 Aug; 18(4):544-51. PubMed ID: 22618270
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T, Sakata Y, Oda K, Aramaki M, Tanaka K, Koga T, Shimada Y, Fujimoto T, Yamashita F, Sakamoto H.
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.